AstraZeneca to buy Fusion Pharmaceuticals for up to $2.4 billion
[ad_1]
AstraZeneca is buying Fusion Pharmaceuticals for $2.4 billion as the London-listed group looks to build its presence in cutting-edge cancer treatments.
[ad_2]
Source link
